Why the study?
Does enhanced patient monitoring and biomarker measurement improve outcomes in patients undergoing major noncardiac surgery?
Does enhanced patient monitoring and biomarker measurement improve outcomes in patients undergoing major noncardiac surgery?
Highlights the significant global burden of perioperative cardiac complications and suggests enhanced monitoring and biomarker measurement to improve outcomes.
High perioperative cardiac burden does not support enhanced monitoring; low-certainty evidence leaves optimal strategies open.
Each year, cardiac complications occur within 30 days after major noncardiac surgery in more than 10 million people worldwide; postoperative mortality is 1.5%. Enhanced patient monitoring and measurement of natriuretic hormone and troponin levels may improve outcomes.
No takes yet. Share an insight, caveat, or question.
Devereaux et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: